{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:16:04Z","timestamp":1778667364157,"version":"3.51.4"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejps.2014.05.028","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T15:31:54Z","timestamp":1401982314000},"page":"227-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Development of novel carrier(s) mediated tuberculosis vaccine: More than a tour de force"],"prefix":"10.1016","volume":"62","author":[{"given":"Neeraj K.","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashay","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejram","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev K.","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejps.2014.05.028_b9000","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/icb.2009.14","article-title":"TB vaccines: current status and future perspectives","volume":"87","author":"Aagaard","year":"2009","journal-title":"Immunol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.ejps.2014.05.028_b0005","doi-asserted-by":"crossref","first-page":"e3116","DOI":"10.1371\/journal.pone.0003116","article-title":"Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements","volume":"3","author":"Agger","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2014.05.028_b0010","doi-asserted-by":"crossref","DOI":"10.1111\/1348-0421.12027","article-title":"Enhanced protection against pulmonary mycobacterial challenge by chitosan-formulated polyepitope gene vaccine was associated with elevated pulmonary SIgA and IFN-gamma(+) T cell response","author":"Ai","year":"2013","journal-title":"Microbiol. Immunol."},{"issue":"23","key":"10.1016\/j.ejps.2014.05.028_b0015","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1016\/j.vaccine.2007.03.039","article-title":"Oral administration of BCG encapsulated in alginate microspheres induces strong Th1 response in BALB\/c mice","volume":"25","author":"Ajdary","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0020","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1128\/IAI.01290-06","article-title":"The combined CTA1-DD\/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis","volume":"75","author":"Andersen","year":"2007","journal-title":"Infect. Immun."},{"issue":"40","key":"10.1016\/j.ejps.2014.05.028_b9005","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1016\/j.vaccine.2011.07.039","article-title":"Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis","volume":"29","author":"Ballester","year":"2011","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.ejps.2014.05.028_b0030","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1089\/10430349950016816","article-title":"Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection","volume":"10","author":"Barry","year":"1999","journal-title":"Hum. Gene Ther."},{"issue":"12","key":"10.1016\/j.ejps.2014.05.028_b0025","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2014.05.028_b0035","first-page":"679","article-title":"Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs","volume":"9","author":"Binjawadagi","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"13\u201314","key":"10.1016\/j.ejps.2014.05.028_b0045","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.vaccine.2003.09.044","article-title":"Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A\u22170201-restricted T-cell epitopes of Mycobacterium tuberculosis","volume":"22","author":"Bivas-Benita","year":"2004","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.ejps.2014.05.028_b0040","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1016\/j.vaccine.2009.04.033","article-title":"Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime\/protein boost vaccination regimen in mice","volume":"27","author":"Bivas-Benita","year":"2009","journal-title":"Vaccine"},{"issue":"5 Suppl.","key":"10.1016\/j.ejps.2014.05.028_b0050","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nm0598supp-480","article-title":"Vaccine visions and their global impact","volume":"4","author":"Bloom","year":"1998","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0055","first-page":"73","article-title":"The role of T-cell subsets in Mycobacterium tuberculosis infection","volume":"5","author":"Boom","year":"1996","journal-title":"Infect. Agents Dis."},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0060","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/IAI.68.2.791-795.2000","article-title":"ESAT-6 subunit vaccination against Mycobacterium tuberculosis","volume":"68","author":"Brandt","year":"2000","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.ejps.2014.05.028_b0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/368096","article-title":"Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guerin vaccination","volume":"187","author":"Brown","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"16","key":"10.1016\/j.ejps.2014.05.028_b0070","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.vaccine.2008.02.023","article-title":"Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli","volume":"26","author":"Brun","year":"2008","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.ejps.2014.05.028_b9015","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1016\/j.vaccine.2005.03.024","article-title":"Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice","volume":"23","author":"Cai","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ejps.2014.05.028_b0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0006-3495(86)83501-9","article-title":"Salt-induced aggregation and fusion of dioctadecyldimethylammonium chloride and sodium dihexadecylphosphate vesicles","volume":"50","author":"Carmona-Ribeiro","year":"1986","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.femsim.2004.01.004","article-title":"Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge","volume":"41","author":"Chambers","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"6","key":"10.1016\/j.ejps.2014.05.028_b9020","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00436-005-0088-5","article-title":"Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection","volume":"98","author":"Coelho","year":"2006","journal-title":"Parasitol. Res."},{"issue":"7","key":"10.1016\/j.ejps.2014.05.028_b0085","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","article-title":"Nanotechnology: intelligent design to treat complex disease","volume":"23","author":"Couvreur","year":"2006","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0264-410X(00)00102-X","article-title":"Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosis","volume":"19","author":"da Fonseca","year":"2000","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.ejps.2014.05.028_b0095","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1128\/IAI.73.10.6846-6851.2005","article-title":"Antibody profiles characteristic of Mycobacterium tuberculosis infection state","volume":"73","author":"Davidow","year":"2005","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.colsurfb.2009.05.013","article-title":"The synergy between structural stability and DNA-binding controls the antibody production in EPC\/DOTAP\/DOPE liposomes and DOTAP\/DOPE lipoplexes","volume":"73","author":"de la Torre","year":"2009","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2014.05.028_b0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1479-0556-5-2","article-title":"Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs","volume":"5","author":"de Paula","year":"2007","journal-title":"Genet. Vaccines Ther."},{"issue":"10","key":"10.1016\/j.ejps.2014.05.028_b0110","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1128\/IAI.73.10.6711-6720.2005","article-title":"Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies","volume":"73","author":"de Valliere","year":"2005","journal-title":"Infect. Immun."},{"issue":"24","key":"10.1016\/j.ejps.2014.05.028_b0115","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/sj.gt.3301347","article-title":"Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells","volume":"7","author":"Denis-Mize","year":"2000","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.ejps.2014.05.028_b0120","doi-asserted-by":"crossref","first-page":"e32959","DOI":"10.1371\/journal.pone.0032959","article-title":"Formulation of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG in cationic liposomes significantly enhances protection against tuberculosis","volume":"7","author":"Derrick","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b9025","first-page":"19","article-title":"Protective efficacy of mycobacterial 71-kDa cell wall associated protein using poly (DL-lactide-co-glycolide) microparticles as carrier vehicles","volume":"21","author":"Dhiman","year":"1998","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.ejps.2014.05.028_b0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.ejps.2014.05.028_b0130","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0025-7125(16)30190-0","article-title":"Immunology of tuberculosis","volume":"77","author":"Dunlap","year":"1993","journal-title":"Med. Clin. North Am."},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1124\/jpet.105.093351","article-title":"Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin","volume":"316","author":"Ebihara","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/emmm.200900014","article-title":"Innate instruction of adaptive immunity revisited: the inflammasome","volume":"1","author":"Eisenbarth","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejps.2014.05.028_b0145","doi-asserted-by":"crossref","unstructured":"Elvang, T., Christensen, J.P., Billeskov, R., Thi Kim Thanh Hoang, T., Holst, P., Thomsen, A.R., Andersen, P., Dietrich, J., 2009. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination. PLoS One 4(4), e5139.","DOI":"10.1371\/journal.pone.0005139"},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.09-0903","article-title":"Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB","volume":"137","author":"Eum","year":"2010","journal-title":"Chest"},{"issue":"15\u201316","key":"10.1016\/j.ejps.2014.05.028_b9035","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.vaccine.2003.10.035","article-title":"A single vaccination with protein-microspheres elicits a strong CD8 T-cell-mediated immune response against Mycobacterium tuberculosis antigen Mtb8.4","volume":"22","author":"Evans","year":"2004","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.ejps.2014.05.028_b0155","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1073\/pnas.95.16.9477","article-title":"T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles","volume":"95","author":"Fehr","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ejps.2014.05.028_b0160","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/315466","article-title":"CD4+ and CD8+ T cells mediate adoptive immunity to aerosol infection of Mycobacterium bovis bacillus Calmette-Guerin","volume":"181","author":"Feng","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejps.2014.05.028_b0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tim.2005.01.005","article-title":"What\u2019s good for the host is good for the bug","volume":"13","author":"Flynn","year":"2005","journal-title":"Trends Microbiol."},{"issue":"4","key":"10.1016\/j.ejps.2014.05.028_b0170","first-page":"369","article-title":"The adjuvant activity of aliphatic nitrogenous bases","volume":"11","author":"Gall","year":"1966","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/187221110791185015","article-title":"Mucosal delivery of vaccines: role of mucoadhesive\/biodegradable polymers","volume":"4","author":"Garg","year":"2010","journal-title":"Recent Patents Drug Deliv. Form."},{"issue":"12","key":"10.1016\/j.ejps.2014.05.028_b0180","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.4049\/jimmunol.166.12.7033","article-title":"Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response","volume":"166","author":"Giacomini","year":"2001","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ejps.2014.05.028_b0185","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ejps.2014.05.028_b0190","doi-asserted-by":"crossref","first-page":"e6950","DOI":"10.1371\/journal.pone.0006950","article-title":"A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A\u22170201 transgenic mice","volume":"4","author":"Gram","year":"2009","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ejps.2014.05.028_b9040","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1128\/IAI.01781-05","article-title":"Enhanced immunogenicity and protective efficacy with the use of interleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination","volume":"74","author":"Ha","year":"2006","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1021\/mp100208f","volume":"8","author":"Henriksen-Lacey","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.05.028_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)00401-X","article-title":"Immune regulation by B cells and antibodies a view towards the clinic","volume":"98","author":"Hoehlig","year":"2008","journal-title":"Adv. Immunol."},{"issue":"5","key":"10.1016\/j.ejps.2014.05.028_b0205","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1086\/520662","article-title":"Evaluation of Mycobacterium tuberculosis-specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark","volume":"45","author":"Hoff","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"9633","key":"10.1016\/j.ejps.2014.05.028_b0210","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(08)61036-3","article-title":"Tuberculosis vaccine development: goals, immunological design, and evaluation","volume":"372","author":"Hoft","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejps.2014.05.028_b0215","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/IAI.72.3.1608-1617.2004","article-title":"Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines","volume":"72","author":"Holten-Andersen","year":"2004","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.ejps.2014.05.028_b0220","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.ejps.2014.05.028_b0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tube.2006.12.006","article-title":"Should a new tuberculosis vaccine be administered intranasally?","volume":"87","author":"Kallenius","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"issue":"12","key":"10.1016\/j.ejps.2014.05.028_b0230","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1128\/IAI.71.12.7099-7108.2003","article-title":"Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity","volume":"71","author":"Kaplan","year":"2003","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.ejps.2014.05.028_b0235","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1462-5822.2008.01177.x","article-title":"ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection","volume":"10","author":"Koo","year":"2008","journal-title":"Cell Microbiol"},{"issue":"9","key":"10.1016\/j.ejps.2014.05.028_b0240","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.4049\/jimmunol.165.9.5177","article-title":"Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help","volume":"165","author":"Krishnan","year":"2000","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ejps.2014.05.028_b0245","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1128\/IAI.00015-09","article-title":"The RD1 locus in the Mycobacterium tuberculosis genome contributes to activation of caspase-1 via induction of potassium ion efflux in infected macrophages","volume":"77","author":"Kurenuma","year":"2009","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0250","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/eji.1830250211","article-title":"Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance","volume":"25","author":"Ladel","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"21","key":"10.1016\/j.ejps.2014.05.028_b0255","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2005.08.021","article-title":"DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates","volume":"24","author":"Li","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.ejps.2014.05.028_b0270","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1128\/IAI.69.9.5305-5312.2001","article-title":"Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis","volume":"69","author":"Lima","year":"2001","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0260","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0264-410X(03)00543-7","article-title":"Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo","volume":"22","author":"Lima","year":"2003","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ejps.2014.05.028_b0265","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.gt.3301908","article-title":"Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis","volume":"10","author":"Lima","year":"2003","journal-title":"Gene Ther."},{"issue":"10","key":"10.1016\/j.ejps.2014.05.028_b0275","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1007\/s11095-007-9302-8","article-title":"Poly(lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B","volume":"24","author":"Lu","year":"2007","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.ejps.2014.05.028_b0280","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1023\/A:1020452531828","article-title":"Analysis of poly(d,l-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro","volume":"19","author":"Lutsiak","year":"2002","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0285","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nri1997","article-title":"Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation","volume":"7","author":"Mariathasan","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ejps.2014.05.028_b0290","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1023\/A:1011902532163","article-title":"Aerosol delivery of lipid:DNA complexes to lungs of rhesus monkeys","volume":"15","author":"McDonald","year":"1998","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.ejps.2014.05.028_b0295","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.vaccine.2012.11.075","article-title":"Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system","volume":"31","author":"Meerak","year":"2013","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ejps.2014.05.028_b0300","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1462-5822.2010.01450.x","article-title":"Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3\/ASC inflammasome","volume":"12","author":"Mishra","year":"2010","journal-title":"Cell. Microbiol."},{"issue":"31","key":"10.1016\/j.ejps.2014.05.028_b0305","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1016\/S0264-410X(01)00193-1","article-title":"Towards the rational design of Th1 adjuvants","volume":"19","author":"Moingeon","year":"2001","journal-title":"Vaccine"},{"issue":"21\u201322","key":"10.1016\/j.ejps.2014.05.028_b0310","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.vaccine.2004.05.005","article-title":"Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles","volume":"22","author":"Mollenkopf","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ejps.2014.05.028_b0315","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(00)80106-3","article-title":"Epithelial M cells: gateways for mucosal infection and immunization","volume":"86","author":"Neutra","year":"1996","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ejps.2014.05.028_b0320","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jbm.10019","article-title":"Uptake of poly(d,l-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo","volume":"60","author":"Newman","year":"2002","journal-title":"J. Biomed. Mater. Res."},{"issue":"11","key":"10.1016\/j.ejps.2014.05.028_b0325","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/jmg.32.11.904","article-title":"Evidence for exclusion of a mutation in NRAMP as the cause of familial disseminated atypical mycobacterial infection in a Maltese kindred","volume":"32","author":"Newport","year":"1995","journal-title":"J. Med. Genet."},{"issue":"11","key":"10.1016\/j.ejps.2014.05.028_b0330","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0335","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0264-410X(97)00149-7","article-title":"Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine","volume":"16","author":"Payne","year":"1998","journal-title":"Vaccine"},{"issue":"23\u201324","key":"10.1016\/j.ejps.2014.05.028_b0340","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/S0264-410X(00)00432-1","article-title":"Liposome-mediated DNA vaccination: the effect of vesicle composition","volume":"19","author":"Perrie","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0345","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nbt0298-153","article-title":"Improving protein therapeutics with sustained-release formulations","volume":"16","author":"Putney","year":"1998","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.ejps.2014.05.028_b0350","first-page":"213","article-title":"Immunology of tuberculosis","volume":"120","author":"Raja","year":"2004","journal-title":"Indian J. Med. Res."},{"issue":"6","key":"10.1016\/j.ejps.2014.05.028_b0355","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80149-1","article-title":"Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo","volume":"11","author":"Randolph","year":"1999","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0360","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2249.2004.02618.x","article-title":"The lung cytokine microenvironment influences molecular events in the lymph nodes during Th1 and Th2 respiratory mucosal sensitization to antigen in vivo","volume":"138","author":"Ritz","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejps.2014.05.028_b0365","doi-asserted-by":"crossref","unstructured":"Rosada, R.S., de la Torre, L.G., Frantz, F.G., Trombone, A.P., Zarate-Blades, C.R., Fonseca, D.M., Souza, P.R., Brandao, I.T., Masson, A.P., Soares, E.G., et al., 2008. Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunol. 9(38), 1\u201313, 9\u201338.","DOI":"10.1186\/1471-2172-9-38"},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0370","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcis.2011.09.040","article-title":"Effectiveness, against tuberculosis, of pseudo-ternary complexes: peptide-DNA-cationic liposome","volume":"373","author":"Rosada","year":"2012","journal-title":"J. Colloid Interface Sci."},{"issue":"9","key":"10.1016\/j.ejps.2014.05.028_b0375","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/IAI.73.9.5817-5826.2005","article-title":"Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system","volume":"73","author":"Rosenkrands","year":"2005","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0380","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrmicro1538","article-title":"Who puts the tubercle in tuberculosis?","volume":"5","author":"Russell","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0385","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrmicro1538","article-title":"Who puts the tubercle in tuberculosis?","volume":"5","author":"Russell","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.ejps.2014.05.028_b0395","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni.1781","article-title":"Foamy macrophages and the progression of the human tuberculosis granuloma","volume":"10","author":"Russell","year":"2009","journal-title":"Nat. Immunol."},{"issue":"5980","key":"10.1016\/j.ejps.2014.05.028_b0390","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: what we don\u2019t know can, and does, hurt us","volume":"328","author":"Russell","year":"2010","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ejps.2014.05.028_b0400","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/mol.109.058412","article-title":"A novel tumor-targeted therapy using a claudin-4-targeting molecule","volume":"76","author":"Saeki","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"9\u201310","key":"10.1016\/j.ejps.2014.05.028_b0405","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0264-410X(02)00527-3","article-title":"Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants","volume":"21","author":"Schijns","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ejps.2014.05.028_b0410","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0022-2275(20)43097-4","article-title":"Phospholipid spherules (liposomes) as a model for biological membranes","volume":"9","author":"Sessa","year":"1968","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.ejps.2014.05.028_b0415","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1099\/00222615-48-8-757","article-title":"Adjuvant modulation of T-cell reactivity to 30-kDa secretory protein of Mycobacterium tuberculosis H37Rv and its protective efficacy against experimental tuberculosis","volume":"48","author":"Sharma","year":"1999","journal-title":"J. Med. Microbiol."},{"issue":"7","key":"10.1016\/j.ejps.2014.05.028_b0420","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-138-7-200304010-00011","article-title":"Gene vaccines","volume":"138","author":"Srivastava","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0425","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4049\/jimmunol.171.2.795","article-title":"Innate immunity together with duration of antigen persistence regulate effector T cell induction","volume":"171","author":"Storni","year":"2003","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.ejps.2014.05.028_b9050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jac\/dkm053","article-title":"Antimycobacterial activity of bacteriocins and their complexes with liposomes","volume":"59","author":"Sosunov","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"10","key":"10.1016\/j.ejps.2014.05.028_b0430","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/jbm.820221002","article-title":"Macrophage phagocytosis of biodegradable microspheres composed of l-lactic acid\/glycolic acid homo- and copolymers","volume":"22","author":"Tabata","year":"1988","journal-title":"J. Biomed. Mater. Res."},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0435","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1022271020390","article-title":"Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages","volume":"20","author":"Thiele","year":"2003","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b9055","article-title":"Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery","volume":"20","author":"Todoroff","year":"2013","journal-title":"Eur. J. Pharm. Biopharm"},{"issue":"5","key":"10.1016\/j.ejps.2014.05.028_b0440","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1054\/tuld.1999.0215","article-title":"Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis","volume":"79","author":"Tsao","year":"1999","journal-title":"Tuber. Lung Dis."},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0445","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2012.04.037","article-title":"Vaccination strategies against malaria: novel carrier(s) more than a tour de force","volume":"162","author":"Tyagi","year":"2012","journal-title":"J. Controlled Release"},{"issue":"2","key":"10.1016\/j.ejps.2014.05.028_b0450","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CMR.15.2.294-309.2002","article-title":"Innate immunity to Mycobacterium tuberculosis","volume":"15","author":"van Crevel","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.ejps.2014.05.028_b0455","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/art.23286","article-title":"Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: relation to common inflammatory diseases?","volume":"58","author":"Verma","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.ejps.2014.05.028_b0460","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","article-title":"Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates","volume":"76","author":"Via","year":"2008","journal-title":"Infect. Immun."},{"issue":"16","key":"10.1016\/j.ejps.2014.05.028_b0465","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/0264-410X(95)00084-E","article-title":"Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles","volume":"13","author":"Vordermeier","year":"1995","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ejps.2014.05.028_b0470","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2003.08.017","article-title":"Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages","volume":"269","author":"Vyas","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2014.05.028_b0475","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2005.02.003","article-title":"Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages","volume":"296","author":"Vyas","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.05.028_b0480","doi-asserted-by":"crossref","first-page":"591325","DOI":"10.1155\/2011\/591325","article-title":"Liposome technology for industrial purposes","volume":"2011","author":"Wagner","year":"2011","journal-title":"J. Drug Deliv."},{"issue":"5388","key":"10.1016\/j.ejps.2014.05.028_b0490","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.282.5388.476","article-title":"Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.ejps.2014.05.028_b0485","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.vaccine.2010.02.058","article-title":"Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response","volume":"28","author":"Wang","year":"2010","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.ejps.2014.05.028_b0495","doi-asserted-by":"crossref","first-page":"31159","DOI":"10.1074\/jbc.M111.241802","article-title":"ClpR protein-like regulator specifically recognizes RecA protein-independent promoter motif and broadly regulates expression of DNA damage-inducible genes in mycobacteria","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ejps.2014.05.028_b0500","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/jps.20728","article-title":"A practical approach to the use of nanoparticles for vaccine delivery","volume":"95","author":"Wendorf","year":"2006","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2014.05.028_b9060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(99)00200-8","article-title":"Enhancement of the human T cell response to culture filtrate fractions of Mycobacterium tuberculosis by microspheres","volume":"235","author":"Wilkinson","year":"2000","journal-title":"J. Immunol. Methods"},{"issue":"8","key":"10.1016\/j.ejps.2014.05.028_b0505","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.nano.2012.02.015","article-title":"Nanoparticle-based adjuvant for enhanced protective efficacy of DNA vaccine Ag85A-ESAT-6-IL-21 against Mycobacterium tuberculosis infection","volume":"8","author":"Yu","year":"2012","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.ejps.2014.05.028_b0510","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejpb.2006.11.028","article-title":"Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis","volume":"66","author":"Zhu","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714002577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714002577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:36:48Z","timestamp":1649205408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098714002577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":112,"alternative-id":["S0928098714002577"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2014.05.028","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel carrier(s) mediated tuberculosis vaccine: More than a tour de force","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2014.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}